Rise and shine, everyone. Another busy day is on the way. 'Tis the middle of the week, after all. And you know what that means - a cup of stimulation in each hand. Yes, indeed, we are quaffing at a rapid pace this morning as we attempt to keep up with the flow of interesting information to peruse and pursue. Of course, you have your own proverbial mountains to climb. So time to get going. Here are a few tidbits to get you started. Have a smashing day and stay in touch...
Statins Often Prescribed Without Good Evidence (Reuters)
Shire Buys Premacure And An Infant Eye Drug (Pharma Times)
FDA Updates Dispute Resolution Guidance (BioCentury)
Pandemix Flu Vaccines Linked To Guillain-Barre Syndrome (MedPage Today)
Lupin May Spent Up To $1B To Buy Brands In The US (Bloomberg News)
Florida County OKs Incentives For 100 Pharma Jobs (Broward County Business Journal)
Merck Hid Fosamax Bone-Weakening Risks: Lawyer (Bloomberg News)
Jobs Training Grant Aimed At Laid Off Pharma Workers (Star-Ledger of NJ)
EDITOR'S NOTE: Please check this post for additional stories during the day
morning coffee pic thx to chichacha on flickr